- Home
- Publications
- Publication Search
- Publication Details
Title
The evolution of antiplatelet therapy in cardiovascular disease
Authors
Keywords
-
Journal
Nature Reviews Cardiology
Volume 8, Issue 10, Pages 547-559
Publisher
Springer Nature
Online
2011-07-12
DOI
10.1038/nrcardio.2011.96
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Aspirin to Prevent Cardiovascular Disease: The Association of Aspirin Dose and Clopidogrel With Thrombosis and Bleeding
- (2013) Steven R. Steinhubl ANNALS OF INTERNAL MEDICINE
- Meta-Analysis of Multiple Primary Prevention Trials of Cardiovascular Events Using Aspirin
- (2011) Alfred A. Bartolucci et al. AMERICAN JOURNAL OF CARDIOLOGY
- Randomized Trial of Atopaxar in the Treatment of Patients With Coronary Artery Disease
- (2011) Stephen D. Wiviott et al. CIRCULATION
- Safety and Tolerability of Atopaxar in the Treatment of Patients With Acute Coronary Syndromes
- (2011) Michelle L. O'Donoghue et al. CIRCULATION
- High Versus Standard Clopidogrel Maintenance Dose After Percutaneous Coronary Intervention and Effects on Platelet Inhibition, Endothelial Function, and Inflammation
- (2011) Giuseppe Patti et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Multicenter Randomized Trial Evaluating the Efficacy of Cilostazol on Ischemic Vascular Complications After Drug-Eluting Stent Implantation for Coronary Heart Disease
- (2011) Jung-Won Suh et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Glycoprotein IIb/IIIa Inhibitors
- (2011) Deepak L. Bhatt JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Calcium-Channel Blockers Do Not Alter the Clinical Efficacy of Clopidogrel After Myocardial Infarction
- (2011) Jonas B. Olesen et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Terutroban versus aspirin in patients with cerebral ischaemic events (PERFORM): a randomised, double-blind, parallel-group trial
- (2011) Marie-Germaine Bousser et al. LANCET
- Efficacy of Cilostazol in reducing restenosis in patients undergoing contemporary stent based PCI: a meta-analysis of randomised controlled trials
- (2011) Umesh Tamhane et al. EuroIntervention
- Predictive value of post-treatment platelet reactivity for occurrence of post-discharge bleeding after non-ST elevation acute coronary syndrome.
- (2011) Thomas Cuisset et al. EuroIntervention
- Rationale and design of the randomized, double-blind trial testing INtraveNous and Oral administration of elinogrel, a selective and reversible P2Y12-receptor inhibitor, versus clopidogrel to eVAluate Tolerability and Efficacy in nonurgent Percutaneous Coronary Interventions patients (INNOVATE-PCI)
- (2010) Sergio Leonardi et al. AMERICAN HEART JOURNAL
- Randomized comparison of platelet function monitoring to adjust antiplatelet therapy versus standard of care: Rationale and design of the Assessment with a double Randomization of (1) a fixed dose versus a monitoring-guided dose of aspirin and Clopidogrel after DES implantation, and (2) Treatment Interruption versus Continuation, 1 year after stenting (ARCTIC) study
- (2010) Jean-Philippe Collet et al. AMERICAN HEART JOURNAL
- Intracoronary Eptifibatide Bolus Administration During Percutaneous Coronary Revascularization for Acute Coronary Syndromes With Evaluation of Platelet Glycoprotein IIb/IIIa Receptor Occupancy and Platelet Function
- (2010) Albert J. Deibele et al. CIRCULATION
- 2010 Clinical Trial/Clinical Science Abstracts
- (2010) CIRCULATION
- Response to Ticagrelor in Clopidogrel Nonresponders and Responders and Effect of Switching Therapies
- (2010) Paul A. Gurbel et al. CIRCULATION
- Ticagrelor Versus Clopidogrel in Patients With ST-Elevation Acute Coronary Syndromes Intended for Reperfusion With Primary Percutaneous Coronary Intervention
- (2010) Philippe Gabriel Steg et al. CIRCULATION
- First Analysis of the Relation Between CYP2C19 Genotype and Pharmacodynamics in Patients Treated With Ticagrelor Versus Clopidogrel
- (2010) Udaya S. Tantry et al. Circulation-Cardiovascular Genetics
- Adding Cilostazol to Dual Antiplatelet Therapy Achieves Greater Platelet Inhibition than High Maintenance Dose Clopidogrel in Patients With Acute Myocardial Infarction
- (2010) Young-Hoon Jeong et al. Circulation-Cardiovascular Interventions
- Double-blind, placebo-controlled Phase II studies of the protease-activated receptor 1 antagonist E5555 (atopaxar) in Japanese patients with acute coronary syndrome or high-risk coronary artery disease
- (2010) S. Goto et al. EUROPEAN HEART JOURNAL
- The State of Periprocedural Antiplatelet Therapy After Recent Trials
- (2010) Nihar R. Desai et al. JACC-Cardiovascular Interventions
- Reduced-Function CYP2C19 Genotype and Risk of Adverse Clinical Outcomes Among Patients Treated With Clopidogrel Predominantly for PCI
- (2010) Jessica L. Mega et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Comparison of Platelet Function Tests in Predicting Clinical Outcome in Patients Undergoing Coronary Stent Implantation
- (2010) Nicoline J. Breet JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Increased Platelet Inhibition After Switching From Maintenance Clopidogrel to Prasugrel in Patients With Acute Coronary Syndromes
- (2010) Dominick J. Angiolillo et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Ticagrelor Versus Clopidogrel in Patients With Acute Coronary Syndromes Undergoing Coronary Artery Bypass Surgery
- (2010) Claes Held et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Mechanisms Potentially Contributing to the Reduction in Mortality Associated With Ticagrelor Therapy⁎⁎Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology.
- (2010) David J. Schneider JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (PLATO): a randomised double-blind study
- (2010) Christopher P Cannon et al. LANCET
- Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial
- (2010) Shamir R Mehta et al. LANCET
- Genetic variants in ABCB1 and CYP2C19 and cardiovascular outcomes after treatment with clopidogrel and prasugrel in the TRITON–TIMI 38 trial: a pharmacogenetic analysis
- (2010) Jessica L Mega et al. LANCET
- Effect of CYP2C19 and ABCB1 single nucleotide polymorphisms on outcomes of treatment with ticagrelor versus clopidogrel for acute coronary syndromes: a genetic substudy of the PLATO trial
- (2010) Lars Wallentin et al. LANCET
- Secondary prevention of stroke: can we do better than aspirin?
- (2010) Dharam J Kumbhani et al. LANCET NEUROLOGY
- Paraoxonase-1 is a major determinant of clopidogrel efficacy
- (2010) Heleen J Bouman et al. NATURE MEDICINE
- Antiplatelet therapies for the treatment of cardiovascular disease
- (2010) Alan D. Michelson NATURE REVIEWS DRUG DISCOVERY
- Clopidogrel with or without Omeprazole in Coronary Artery Disease
- (2010) Deepak L. Bhatt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dose Comparisons of Clopidogrel and Aspirin in Acute Coronary Syndromes
- (2010) NEW ENGLAND JOURNAL OF MEDICINE
- Effects ofCYP2C19Genotype on Outcomes of Clopidogrel Treatment
- (2010) Guillaume Paré et al. NEW ENGLAND JOURNAL OF MEDICINE
- Abciximab in Patients With Acute ST-Segment–Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention After Clopidogrel Loading
- (2009) Julinda Mehilli et al. CIRCULATION
- Randomized Double-Blind Assessment of the ONSET and OFFSET of the Antiplatelet Effects of Ticagrelor Versus Clopidogrel in Patients With Stable Coronary Artery Disease
- (2009) Paul A. Gurbel et al. CIRCULATION
- Aspirin Use, Dose, and Clinical Outcomes in Postmenopausal Women With Stable Cardiovascular Disease
- (2009) Jeffrey S. Berger et al.
- Tailoring Antiplatelet Therapy Based on Pharmacogenomics
- (2009) Deepak L. Bhatt JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Association of Cytochrome P450 2C19 Genotype With the Antiplatelet Effect and Clinical Efficacy of Clopidogrel Therapy
- (2009) Alan R. Shuldiner JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Comparison of Omeprazole and Pantoprazole Influence on a High 150-mg Clopidogrel Maintenance Dose
- (2009) Thomas Cuisset et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- 2009 Focused Updates: ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction (Updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention (Updating the 2005 Guideline and 2007 Focused Update)
- (2009) Frederick G. Kushner et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Platelet Reactivity After Clopidogrel Treatment Assessed With Point-of-Care Analysis and Early Drug-Eluting Stent Thrombosis
- (2009) Dirk Sibbing et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial
- (2009) Gilles Montalescot et al. LANCET
- Ticagrelor in ACS—what does PLATO teach us?
- (2009) Deepak L. Bhatt Nature Reviews Cardiology
- Prasugrel in Clinical Practice
- (2009) Deepak L. Bhatt NEW ENGLAND JOURNAL OF MEDICINE
- Early versus Delayed, Provisional Eptifibatide in Acute Coronary Syndromes
- (2009) Robert P. Giugliano et al. NEW ENGLAND JOURNAL OF MEDICINE
- Intravenous Platelet Blockade with Cangrelor during PCI
- (2009) Deepak L. Bhatt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
- (2009) Lars Wallentin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Platelet Inhibition with Cangrelor in Patients Undergoing PCI
- (2009) Robert A. Harrington et al. NEW ENGLAND JOURNAL OF MEDICINE
- Low-Dose Aspirin in Patients with Stable Cardiovascular Disease: A Meta-analysis
- (2008) Jeffrey S. Berger et al. AMERICAN JOURNAL OF MEDICINE
- Greater Clinical Benefit of More Intensive Oral Antiplatelet Therapy With Prasugrel in Patients With Diabetes Mellitus in the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel–Thrombolysis in Myocardial Infarction 38
- (2008) Stephen D. Wiviott et al. CIRCULATION
- Effects of aspirin dose on ischaemic events and bleeding after percutaneous coronary intervention: insights from the PCI-CURE study
- (2008) S. S. Jolly et al. EUROPEAN HEART JOURNAL
- Resisting the Temptation to Oversimplify Antiplatelet Resistance⁎⁎Editorials published in JACC: Cardiovascular Interventions reflect the views of the authors and do not necessarily represent the views of JACC: Cardiovascular Interventions or the American College of Cardiology.
- (2008) Deepak L. Bhatt JACC-Cardiovascular Interventions
- Point-of-Care Measurement of Clopidogrel Responsiveness Predicts Clinical Outcome in Patients Undergoing Percutaneous Coronary Intervention
- (2008) Giuseppe Patti et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Adjusted Clopidogrel Loading Doses According to Vasodilator-Stimulated Phosphoprotein Phosphorylation Index Decrease Rate of Major Adverse Cardiovascular Events in Patients With Clopidogrel Resistance
- (2008) Laurent Bonello et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- What Makes Platelets Angry
- (2008) Deepak L. Bhatt JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- ACCF/ACG/AHA 2008 Expert Consensus Document on Reducing the Gastrointestinal Risks of Antiplatelet Therapy and NSAID Use
- (2008) Deepak L. Bhatt et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Appropriate use of drug-eluting stents: balancing the reduction in restenosis with the concern of late thrombosis
- (2008) Anthony A Bavry et al. LANCET
- Intensive oral antiplatelet therapy for reduction of ischaemic events including stent thrombosis in patients with acute coronary syndromes treated with percutaneous coronary intervention and stenting in the TRITON-TIMI 38 trial: a subanalysis of a randomised trial
- (2008) Stephen D Wiviott et al. LANCET
- Bivalirudin during Primary PCI in Acute Myocardial Infarction
- (2008) Gregg W. Stone et al. NEW ENGLAND JOURNAL OF MEDICINE
- Aspirin and Extended-Release Dipyridamole versus Clopidogrel for Recurrent Stroke
- (2008) Ralph L. Sacco et al. NEW ENGLAND JOURNAL OF MEDICINE
- Facilitated PCI in Patients with ST-Elevation Myocardial Infarction
- (2008) Stephen G. Ellis et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cytochrome P-450 Polymorphisms and Response to Clopidogrel
- (2008) Jessica L. Mega et al. NEW ENGLAND JOURNAL OF MEDICINE
- Aspirin Plus Dipyridamole Versus Aspirin for Prevention of Vascular Events After Stroke or TIA
- (2008) Piero Verro et al. STROKE
- Is prasugrel superior to clopidogrel for patients with acute coronary syndromes undergoing PCI?
- (2008) Deepak L Bhatt Nature clinical practice. Cardiovascular medicine
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started